Merck Animal Health Announces Availability of SEQUIVITY® IAV-S NA for Swine Influenza
The novel vaccine is the first to use only the influenza neuraminidase (NA) surface antigen to vaccinate pigs against influenza strains H1N1, H1N2 and H3N2. RAHWAY, N.J., Nov. 1, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., […]